Find uplifting stories about heroes, innovations, and solutions
44 results for "mrna"
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
A groundbreaking mRNA therapy reduced melanoma recurrence or death by 49% over five years when combined with immunotherapy. The personalized vaccine teaches patients' immune systems to recognize and attack their specific cancer cells.
A $60 million global health initiative is rushing three new vaccine candidates to combat a deadly Ebola outbreak in the Democratic Republic of Congo. The same mRNA technology that helped end the COVID-19 pandemic could now save lives in Central Africa.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
Scientists at MIT have developed a revolutionary cancer vaccine that completely eliminated tumors in most test mice by supercharging the body's T cells. The breakthrough could transform how we fight cancer and infectious diseases.
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
A single shot that protects against both flu and COVID-19 just got approved in Europe, making vaccinations simpler for millions. The combination vaccine showed stronger immune responses than standard shots in trials with 4,000 adults.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
An Australian pet owner with zero scientific background used ChatGPT to design a personalized cancer treatment that saved his dog's life. OpenAI's CEO calls it both inspiring and a wake-up call about AI's growing power.
A 60-year-old melanoma patient in Moscow just received Russia's first personalized mRNA cancer vaccine, designed specifically for their tumor. The breakthrough treatment trains the immune system to target cancer cells unique to each patient.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
Science journalist Matt Kaplan reveals how game-changing discoveries from DNA to mRNA vaccines initially faced fierce resistance, even from experts. His new book celebrates the persistence of scientists who proved the doubters wrong.
Scientists at Harvard have created a new DNA origami vaccine that works as well as mRNA shots but doesn't need freezers and is simpler to manufacture. The breakthrough could make life-saving vaccines accessible to millions more people worldwide.
Showing 20 of 44